The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO GI 2021 | Managing patients with CRC using ctDNA

Name: Managing patients with CRC using ctDNA
Uploaded: 2021-01-22T00:00:00Z
Duration: 5 min 5 s
Description: Arvind Dasari, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the use of ctDNA in the management of patients with colorectal cancer (CRC), including the prognostic value of ctDNA as well as its use in minimal residual disease detection. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Arvind Dasari • 22 Jan 2021

ASCO GI 2021

Colorectal Cancer Gastrointestinal Cancer

Arvind Dasari, MD, MS, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the use of ctDNA in the management of patients with colorectal cancer (CRC), including the prognostic value of ctDNA as well as its use in minimal residual disease detection. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).